Minimally invasive devices used to monitor glycosylated hemoglobin. These monitoring devices provide the average glucose level for a 90-day period. This number is equivalent to checking glucose every second (7.7 million finger sticks) during this period and averaging all these readings. The trend from visit to visit is the best indicator of diabetes care.
| Product Name |
|---|
Bio-Rad Laboratories, Inc. |
FlexSite Diagnostics, Inc. |
Diabetes Technologies, Inc. |
Axis-Shield |
Biosafe Laboratories, Inc. |
Infopia USA, LLC |
Abbott Diabetes Care |
Abbott Diabetes Care |
Abbott Diabetes Care |
Infopia USA, LLC |
Abbott Diabetes Care |